Nine studies (n=2,030) were included in the analysis: five randomised controlled trials (RCTs) (n=1,957); two pre/post tests (n= 52); one survey (n=12); and one was qualitative (n=9). Six studies specified the population was type 2 diabetes (n=249); three studies did not specify the type of diabetes (n=1,781).
Clinical outcomes (seven studies, n=2,009): All studies reported decreased glycosylated haemoglobin indicative of decreased diabetic complications (five RCTs and two pre/post tests). Telediabetes patients reported improved triglyceride/cholesterol levels (three RCTs, n=1,826) and improved blood pressure (two RCTs, n=1,769).
Participant experience (five studies, n=130): Participants had increased satisfaction with web-based programs (one RCT, two pre/post tests, one survey, n= 121) and felt that the programs produced a feeling of security due to increased access to health information and professionals (one qualitative study, n=9). Patients reported dissatisfaction when the program did not work as expected (one qualitative study, n=9).